It is well known that estrogen is strongly associated with the growth of all breast fibroadenomas, and mutation of MED12, essential for activating CDK8 kinase and also playing an important role in the development of uterine leiomyomas, is found in many of them [5]. Here, MED12 is linked to Fibroadenoma.